Torrico M.C., Fernández-Arévalo A., Ballart C., Solano M., Rojas E., Abras A., Gonzales F., Arnau A., Tebar S., Llovet T., Lozano D., Ariza-Vioque E., Gascón J., Picado A., Torrico F., Munoz, C, Gállego M.. Usefulness of Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry in the Characterization of Leishmania Strains Causing Tegumentary Leishmaniasis in Bolivia versus hsp70 Gene Sequencing. Microbiology Spectrum. 2023; 11(1)DOI:10.1128/spectrum.03477-22. PMID:36633426. IF:3.700(Q2/4D).

Becerra-Aparicio F., Gómez-Zorrilla S., Hernández-García M., Gijón D., Siverio A., Berbel D., Sánchez-Carrillo C., Cercenado E., Rivera A., de Malet A., Xercavins M., Ruiz de Gopegui E., Canoura-Fernández L., Martínez J.A., Seral C., Del Pozo J.L., Cotarelo M., Díaz-Regañón J., Cantón R., Oliver A., Horcajada J.P., Ruiz-Garbajosa P.. Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project). JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2023; 78(9)DOI:10.1093/jac/dkad234. PMID:37533351. IF:3.900(Q1/3D).

Sojo-Dorado J., López-Hernández I., Hernández-Torres A., Retamar-Gentil P., Merino De Lucas E., Escolà-Verge L., Bereciartua E., García-Vázquez E., Pintado V., Boix-Palop L., Natera-Kindelán C., Sorlí L., Borrell N., Amador-Prous C., Shaw E., Jover-Saenz A., Molina J., Martínez-Álvarez R.M., Dueñas C.J., Calvo-Montes J., Lecuona M., Pomar V., Borreguero I., Palomo-Jimenez V., Docobo-Perez F., Pascual Á., Rodríguez-Baño J.. Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2023; 78(7)DOI:10.1093/jac/dkad147. PMID:37260299. IF:3.900(Q1/3D).

de Mendoza C., Carrizo P., Sauleda S., Richart A., Rando A., Miró E., Benito R., Ayerdi O., Encinas B., Aguilera A., Reina G., Rojo S., González R., Fernández-Ruiz M., Liendo P., Montiel N., Roc L., Treviño A., Pozuelo M.J., Soriano V.. The slowdown of new infections by human retroviruses has reached a plateau in Spain. JOURNAL OF MEDICAL VIROLOGY. 2023; 95(5)DOI:10.1002/jmv.28779. PMID:37212269. IF:6.800(Q1/1D).

Pérez-Recio S., Grijota-Camino M.D., Anibarro L., Rabuñal-Rey R., Sabria J., Gijón-Vidaurreta P., Pomar V., García-Gasalla M., Domínguez-Castellano Á., Trigo M., Santos M.J., Cebollero A., Rodríguez S., Moga E., Penas-Truque A., Martos C., Ruiz-Serrano M.J., Garcia-De-Cara E.I., Alcaide F., Santin M.. Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation: A prospective multicentre cohort study. PLoS One. 2023; 18(8)DOI:10.1371/journal.pone.0285917. PMID:37647315. IF:2.900(Q1/3D).

Batlle M., Badia J.M., Hernández S., Grau S., Padulles A., Boix-Palop L., Giménez-Pérez M., Ferrer R., Calbo E., Limón E., Pujol M., Horcajada J.P., Smithson A., Ros N.B., Gomila-Grange A., Pomar V., Toboso S.H., Murgadella-Sancho A., Perez-Hita A.O., Temple M.D., Molpeceres S.V., Pardo D.R., Río A.D., Luque M.F.S., Blanco N.V., Acedo S.O., Guitart S.S., Nicolas E.M., Noblia-Gigena L.B., Pérez O.D.R., Rodriguez M.P.G., Barcons I.A., Serra N.J., Calva L.C., Lérida A., Torras S.G., Martínez L.H., Miñambres C., Matellane J.M., Jofre C.S., Estada S.B., Carrascosa M.C., Mota S.T., Barrena D.S.. Reducing the duration of antibiotic therapy in surgical patients through a specific nationwide antimicrobial stewardship program. A prospective, interventional cohort study. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2023; 62(5)DOI:10.1016/j.ijantimicag.2023.106943. PMID:37541529. IF:4.900(Q1/2D).